Alto Neuroscience, Inc. (ANRO) vs LB Pharmaceuticals Inc (LBRX)

Alto Neuroscience, Inc. and LB Pharmaceuticals Inc are both Biotechnology companies. LB Pharmaceuticals Inc is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Across the 10 metrics below, Alto Neuroscience, Inc. leads on 6 and LB Pharmaceuticals Inc on 4.

Valuation

Metric ANRO LBRX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 5.17 3.39 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (9.14%) (9.22%) (28.84%)
Free cash flow yield (6.07%) (7.36%) (23.03%)

Profitability

Metric ANRO LBRX Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.17%) (72.07%) (57.72%)
Return on assets (40.90%) (47.38%) (49.22%)
Return on invested capital 0.00% (1,304.79%) 0.00%

Growth

Metric ANRO LBRX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 12.40% 98.22% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ANRO LBRX Biotechnology median
Debt to equity 0.09 0.00 0.00
Current ratio 14.85 15.08 4.73
Net debt to EBITDA 2.40 9.90 0.96

Dividend

Metric ANRO LBRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric ANRO LBRX Biotechnology median
Market cap 1.07b 1.22b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack